Neogen (NEOG) Scheduled to Post Earnings on Thursday

Neogen (NASDAQ:NEOG) is scheduled to be releasing its earnings data before the market opens on Thursday, October 10th. Analysts expect Neogen to post earnings of $0.10 per share for the quarter. Neogen has set its FY 2025 guidance at EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Neogen (NASDAQ:NEOG) last announced its earnings results on Tuesday, July 30th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). The business had revenue of $236.80 million during the quarter, compared to analysts’ expectations of $225.83 million. Neogen had a negative net margin of 1.02% and a positive return on equity of 3.09%. Neogen’s quarterly revenue was down 2.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.14 earnings per share. On average, analysts expect Neogen to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Neogen Stock Performance

Shares of NEOG stock opened at $15.71 on Thursday. Neogen has a 52-week low of $11.46 and a 52-week high of $20.89. The company has a quick ratio of 2.59, a current ratio of 3.82 and a debt-to-equity ratio of 0.28. The stock’s 50-day moving average price is $16.56 and its 200 day moving average price is $15.22. The stock has a market capitalization of $3.40 billion, a PE ratio of 1,571.00 and a beta of 1.21.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. StockNews.com upgraded shares of Neogen to a “sell” rating in a research report on Monday. Piper Sandler increased their price target on shares of Neogen from $17.00 to $17.50 and gave the stock a “neutral” rating in a report on Tuesday, August 6th.

Insiders Place Their Bets

In related news, Director James P. Tobin purchased 3,000 shares of the business’s stock in a transaction dated Tuesday, August 6th. The stock was acquired at an average price of $16.86 per share, for a total transaction of $50,580.00. Following the acquisition, the director now directly owns 23,392 shares of the company’s stock, valued at approximately $394,389.12. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 0.71% of the company’s stock.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.